Related references
Note: Only part of the references are listed.Impact of NUDT15 genetics on severe thiopurine-related hematotoxicity in patients with European ancestry
Elke Schaeffeler et al.
GENETICS IN MEDICINE (2019)
Prevalence of TPMT, ITPA and NUDT 15 genetic polymorphisms and their relation to 6MP toxicity in north Indian children with acute lymphoblastic leukemia
Sanjeev Khera et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update
Mary Relling et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Preclinical evaluation of NUDT15-guided thiopurine therapy and its effects on toxicity and antileukemic efficacy
Rina Nishii et al.
BLOOD (2018)
Diplotype analysis of NUDT15 variants and 6-mercaptopurine sensitivity in pediatric lymphoid neoplasms
Shinichi Tsujimoto et al.
LEUKEMIA (2018)
Treatment and biology of pediatric acute lymphoblastic leukemia
Motohiro Kato et al.
PEDIATRICS INTERNATIONAL (2018)
Predictive role of NUDT15 variants on thiopurine-induced myelotoxicity in Asian inflammatory bowel disease patients
Natalia Sutiman et al.
PHARMACOGENOMICS (2018)
NUDT15 Hydrolyzes 6-Thio-DeoxyGTP to Mediate the Anticancer Efficacy of 6-Thioguanine
Nicholas C. K. Valerie et al.
CANCER RESEARCH (2016)
NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity
Takaya Moriyama et al.
NATURE GENETICS (2016)
Susceptibility to 6-MP toxicity conferred by a NUDT15 variant in Japanese children with acute lymphoblastic leukaemia
Yoichi Tanaka et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Inherited NUDT15 Variant Is a Genetic Determinant of Mercaptopurine Intolerance in Children With Acute Lymphoblastic Leukemia
Jun J. Yang et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia
Suk-Kyun Yang et al.
NATURE GENETICS (2014)
Share Paper
